Who writes and reviews this
Authors and Analysts
Every page carries the name of the person who wrote it and, where clinical statements appear, the clinician who reviewed it. Credentials shown here are verified with the issuing board and re-checked on a schedule. None have been verified yet in this build.
Dr. Parmis
credential pending verification
Verification pending
Confirm full legal name, degree, license number, issuing state, current status and biography before any byline publishes.
Jonathan Michael Snipes, MD
MD · NPI 1821250077
Verification pending
NPI is active in NPPES. An NPI does not establish current state licensure or credentialing — verify each displayed license with the issuing board and record the check in the ledger.
Kimberly Dianne Callender, FNP-BC
FNP-BC · NPI 1144661760
Verification pending
Verify current credentials, board certification status and every state license before publication.
| Person | Identity record | State licence | Board certification | Re-check due |
|---|---|---|---|---|
| Dr. Parmis | not verified | not verified | not verified | not verified |
| Jonathan Michael Snipes, MD | NPI 1821250077 Provider-reported | not verified | not verified | not verified |
| Kimberly Dianne Callender, FNP-BC | NPI 1144661760 Provider-reported | not verified | not verified | not verified |
Show this figure as a table
| Step | Stage | What happens |
|---|---|---|
| 1 | Collect the claimed credential | Degree, licence number, issuing state, certification body. |
| 2 | Check with the issuing board | The board's own lookup, not the person's CV or a directory. |
| 3 | Record the check | Evidence ID, capture date, screenshot, reviewer. |
| 4 | Set a re-check date | Licences lapse quietly; the date forces a re-look. |
| 5 | Publish only then | No byline appears before this sequence completes. |
- Confirm the editorial lead's full legal name, degree, licence number, issuing state and current status. No byline publishes without it.
- Verify each reviewer's state licences with the issuing board directly. An active NPI records identity, not licensure or credentialing.
- Record every verification in the source ledger with a capture date and a next-review date.
- Do not publish a reviewer's name on a page they have not actually reviewed.
What a byline means here
An author byline means that person wrote or substantively edited the page. A reviewer byline means a named clinician read that specific page and checked its clinical statements against their cited sources.
Neither appears sitewide by default. A byline that attaches automatically to every page is a design element rather than an attribution, and it is how most publications in this category present authorship.
What a reviewer actually does
Opens the cited paper and confirms our sentence says what that paper says. Confirms which analysis produced any quoted figure. Checks that limitation sections survived editing, since those are what get cut when a draft runs long. And checks that no sentence reads as advice for an individual reader — no dose, no eligibility verdict, no “you should”.
Credential verification status
An NPI number establishes identity in the national NPPES registry. It is not evidence of current state licensure, board certification or credentialing — those are separate records held by separate bodies.
Where we have not completed those checks, no medically-reviewed byline publishes and no review date is emitted. Every byline on such a page reads “medically reviewed: not yet” and links to an explanation. That is the correct holding position, and it is uncomfortable to publish, which is why almost nobody does.
Related on this site
- GLP-1 Tirzepatide Reviews: Evidence, Prices, Providers & ToolsCore & Trust
- About GLP-1 Tirzepatide ReviewsCore & Trust
- Editorial StandardsCore & Trust
- Provider Ranking MethodologyCore & Trust
- All-in cost toolTools
- Price records, machine-readableData
- GLP-1 Data API DocumentationData
- Found vs Henry MedsComparisons
- Found Tirzepatide ReviewProviders
- Enhance.MD Tirzepatide ReviewProviders
Related coverage
- Cheapest tirzepatide, answered six ways
- What you pay at a maintenance dose
- Henry Meds vs Hims
- LillyDirect vs MEDVi
- NexLife vs Shed
- Zepbound vs Compounded Tirzepatide
- Counterfeits, Research Peptides and the Grey Market: How to Stay Inside the System
- SOUL: Oral Semaglutide Cuts Major Cardiovascular Events by 14% in High-Risk Type 2 Diabetes
- Ro Body Tirzepatide Review
GLP-1 Tirzepatide Reviews. “Authors and Analysts.” S.J Partners LLC, 2026-07-24. https://glptirzepatidereviews.com/authors/
When quoting a figure, include the capture date shown beside it rather than the date you read this page. A price without its capture date is not a usable citation.